Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-236-1 | CAS number: 1314-56-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
refer to "Justification for classification"
Short description of key information:
Diphosphorus pentaoxide is a hygroscopic solid which forms with moisture/water an aqueous solution of phosphorus oxyacids (primary hydrolysis) that are subject to further (secondary) hydrolysis to the end product phosphoric acid, H3PO4. The exposure to Diphosphorus pentaoxide under physiological conditions (aqueous system) will principally lead to local (genotoxic) effects due to the strong corrosivity of the generated phosphoric acid. Therefore, a read across to the data generated with Phosphoric acid is justified.
Mutagenic activity of Phosphoric acid was investigated in two bacterial reverse mutation assays (Ames test; test strains used: S. typhimurium TA97, TA 98, TA 100, TA 104, TA 1535, TA 1537 and E. coli WP2 uvr A), and in an in vitro chromosome aberration study in mammalian cells (Chinese Hamster Lung). Negative results were obtained in all tests with and without metabolic activation.
Furthermore, no genotoxcity was observed in a gene mutation study (HPRT test) with Diphosphorus pentaoxide performed in V79 Chinese hamster lung fibroblasts.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Diphosphorus pentaoxide is a hygroscopic solid which forms with moisture/water an aqueous solution of phosphorus oxyacids (primary hydrolysis) that are subject to further (secondary) hydrolysis to the end product phosphoric acid, H3PO4. The exposure to Diphosphorus pentaoxide under physiological conditions (aqueous system) will principally lead to local (genotoxic) effects due to the strong corrosivity of the generated phosphoric acid. Therefore, a read across to the data generated with Phosphoric acid is justified.
Phosphoric acid did not show chromosome aberrations regardless of application of metabolic activiation in a chromosome aberration study using Chinese hamster lung cells (CHL/IU). Phosphoric acid was also considered to be non-genotoxic in the bacterial reverse mutation test.
Furthermore, no genotoxcity was observed in a gene mutation study (HPRT test) with Diphosphorus pentaoxide performed in V79 Chinese hamster lung fibroblasts.
It can be concluded from the data available that mutagenicity and genotoxicity are not caused by Phosphoric acid and also by Diphosphorus pentaoxide (which hydrolyses in aqueous solutions completely to Phosphoric acid). Therefore, a classification for this endpoint is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
